I. Wivall-Helleryd

Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects.

M. Thorén, K. Hall, A. Hilding, 1999, The Journal of clinical endocrinology and metabolism.

Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.

R. Baxter, M. Thorén, K. Hall, 1997, The Journal of clinical endocrinology and metabolism.

Specific cleavage of insulin-like growth factor-binding protein-1 by a novel protease activity

H. Jörnvall, M. Ståhlberg, J. Zierath, 2006, Cellular and Molecular Life Sciences CMLS.

Responses of insulin-like growth factor (IGF)-I and IGF-binding proteins to nutritional status in peroxisome proliferator-activated receptor-alpha knockout mice.

T. Bergman, F. Gonzalez, K. Brismar, 2001, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Effects of recombinant human insulin‐like growth factor I administration in adults with growth hormone deficiency

M. Thorén, K. Hall, I. Wivall-Helleryd, 1993, Acta paediatrica (Oslo, Norway : 1992). Supplement.

Effects of repeated subcutaneous administration of recombinant human insulin-like growth factor I in adults with growth hormone deficiency.

M. Thorén, K. Hall, W. Blum, 1994, European Journal of Endocrinology.